Clinical comparison and complete cure rates of terbinafine efficacy in affected onychomycotic toenails
Journal of the European Academy of Dermatology and Venereology2014Vol. 29(3), pp. 521–526
Citations Over TimeTop 22% of 2014 papers
Avner Shemer, Nicole Sakka, Robert Baran, R K Scher, Boaz Amichai, Louis Norman, Renata Farhi, R. Magun, A. Brazilai, Ralph Daniel
Abstract
Our results support findings that efficacy of Terbinafine should be based on all involved onychomycotic toenails; the big toenail is not superior in response compared to other affected toenails.
Related Papers
- → Terbinafine-induced lichenoid drug eruption: case report and review of terbinafine-associated cutaneous adverse events(2020)13 cited
- → Clinical comparison and complete cure rates of terbinafine efficacy in affected onychomycotic toenails(2014)12 cited
- → Safety of terbinafine: results of a postmarketing surveillance study in 25,884 patients(1998)
- Clinical Observation on 83 Cases of Onychomycosis Treated with Oral Terbinafine(2009)
- Efficacy and Security Evaluation of Terbinafine for Tinea Capitis in 59 Children(2008)